Cargando…
Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients
Upper extremity digital ischaemia (UEDI) is a rare heterogeneous condition whose frequency is 40 times less than that of toe ischaemia. Using a large cohort, the aim of this study was to evaluate aetiologies, prognosis and midterm clinical outcomes of UEDI. All patients with UEDI with or without cut...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136985/ https://www.ncbi.nlm.nih.gov/pubmed/34011027 http://dx.doi.org/10.1097/MD.0000000000025659 |
_version_ | 1783695532629164032 |
---|---|
author | Raimbeau, Alizée Pistorius, Marc-Antoine Goueffic, Yann Connault, Jérôme Plissonneau-Duquene, Pierre Maurel, Blandine Reignier, Jean Asehnoune, Karim Artifoni, Mathieu Didier, Quentin Gautier, Giovanni Trochu, Jean-Nöel Rozec, Bertrand N’Gohou, Chan Durant, Cécile Pottier, Pierre Denis Le Sève, Julien Brebion, Nicolas Agard, Christian Espitia, Olivier |
author_facet | Raimbeau, Alizée Pistorius, Marc-Antoine Goueffic, Yann Connault, Jérôme Plissonneau-Duquene, Pierre Maurel, Blandine Reignier, Jean Asehnoune, Karim Artifoni, Mathieu Didier, Quentin Gautier, Giovanni Trochu, Jean-Nöel Rozec, Bertrand N’Gohou, Chan Durant, Cécile Pottier, Pierre Denis Le Sève, Julien Brebion, Nicolas Agard, Christian Espitia, Olivier |
author_sort | Raimbeau, Alizée |
collection | PubMed |
description | Upper extremity digital ischaemia (UEDI) is a rare heterogeneous condition whose frequency is 40 times less than that of toe ischaemia. Using a large cohort, the aim of this study was to evaluate aetiologies, prognosis and midterm clinical outcomes of UEDI. All patients with UEDI with or without cutaneous necrosis in a university hospital setting between January 2000 to December 2016 were included. Aetiologies, recurrence of UEDI, digital amputation and survival were analyzed retrospectively. Three hundred twenty three patients were included. UEDI due to cardio-embolic disease (DICE) was the highest occurring aetiology with 59 patients (18.3%), followed by DI due to Systemic Sclerosis (SSc) (16.1%), idiopathic causes (11.7%), Thromboangiitis obliterans (TAO) (9.3%), iatrogenic causes (9.3%), and cancer (6.2%). DICE patients tended to be older and featured more cases with arterial hypertension whereas TAO patients smoked more tobacco and cannabis. During follow-up, recurrences were significantly more frequent in SSc than in all other tested groups (P < .0001 vs idiopathic and DICE, P = .003 vs TAO) and among TAO patients when compared to DICE patients (P = .005). The cumulated rate of digital amputation was higher in the SSc group (n = 18) (P = .02) and the TAO group (n = 7) (P = .03) than in DICE (n = 2). This retrospective study suggests that main aetiologies of UEDI are DICE, SSc and idiopathic. This study highlights higher frequency of iatrogenic UEDI than previous studies. UEDI associated with SSc has a poor local prognosis (amputations and recurrences) and DICE a poor survival. UEDI with SSc and TAO are frequently recurrent. |
format | Online Article Text |
id | pubmed-8136985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-81369852021-05-25 Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients Raimbeau, Alizée Pistorius, Marc-Antoine Goueffic, Yann Connault, Jérôme Plissonneau-Duquene, Pierre Maurel, Blandine Reignier, Jean Asehnoune, Karim Artifoni, Mathieu Didier, Quentin Gautier, Giovanni Trochu, Jean-Nöel Rozec, Bertrand N’Gohou, Chan Durant, Cécile Pottier, Pierre Denis Le Sève, Julien Brebion, Nicolas Agard, Christian Espitia, Olivier Medicine (Baltimore) 3400 Upper extremity digital ischaemia (UEDI) is a rare heterogeneous condition whose frequency is 40 times less than that of toe ischaemia. Using a large cohort, the aim of this study was to evaluate aetiologies, prognosis and midterm clinical outcomes of UEDI. All patients with UEDI with or without cutaneous necrosis in a university hospital setting between January 2000 to December 2016 were included. Aetiologies, recurrence of UEDI, digital amputation and survival were analyzed retrospectively. Three hundred twenty three patients were included. UEDI due to cardio-embolic disease (DICE) was the highest occurring aetiology with 59 patients (18.3%), followed by DI due to Systemic Sclerosis (SSc) (16.1%), idiopathic causes (11.7%), Thromboangiitis obliterans (TAO) (9.3%), iatrogenic causes (9.3%), and cancer (6.2%). DICE patients tended to be older and featured more cases with arterial hypertension whereas TAO patients smoked more tobacco and cannabis. During follow-up, recurrences were significantly more frequent in SSc than in all other tested groups (P < .0001 vs idiopathic and DICE, P = .003 vs TAO) and among TAO patients when compared to DICE patients (P = .005). The cumulated rate of digital amputation was higher in the SSc group (n = 18) (P = .02) and the TAO group (n = 7) (P = .03) than in DICE (n = 2). This retrospective study suggests that main aetiologies of UEDI are DICE, SSc and idiopathic. This study highlights higher frequency of iatrogenic UEDI than previous studies. UEDI associated with SSc has a poor local prognosis (amputations and recurrences) and DICE a poor survival. UEDI with SSc and TAO are frequently recurrent. Lippincott Williams & Wilkins 2021-05-21 /pmc/articles/PMC8136985/ /pubmed/34011027 http://dx.doi.org/10.1097/MD.0000000000025659 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | 3400 Raimbeau, Alizée Pistorius, Marc-Antoine Goueffic, Yann Connault, Jérôme Plissonneau-Duquene, Pierre Maurel, Blandine Reignier, Jean Asehnoune, Karim Artifoni, Mathieu Didier, Quentin Gautier, Giovanni Trochu, Jean-Nöel Rozec, Bertrand N’Gohou, Chan Durant, Cécile Pottier, Pierre Denis Le Sève, Julien Brebion, Nicolas Agard, Christian Espitia, Olivier Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients |
title | Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients |
title_full | Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients |
title_fullStr | Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients |
title_full_unstemmed | Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients |
title_short | Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients |
title_sort | digital ischaemia aetiologies and mid-term follow-up: a cohort study of 323 patients |
topic | 3400 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136985/ https://www.ncbi.nlm.nih.gov/pubmed/34011027 http://dx.doi.org/10.1097/MD.0000000000025659 |
work_keys_str_mv | AT raimbeaualizee digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT pistoriusmarcantoine digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT gouefficyann digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT connaultjerome digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT plissonneauduquenepierre digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT maurelblandine digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT reignierjean digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT asehnounekarim digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT artifonimathieu digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT didierquentin digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT gautiergiovanni digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT trochujeannoel digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT rozecbertrand digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT ngohouchan digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT durantcecile digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT pottierpierre digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT denislesevejulien digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT brebionnicolas digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT agardchristian digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients AT espitiaolivier digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients |